SLF-amido-C2-COOH is a synthetic FKBP12-binding ligand functionalized with a carboxylic acid handle for PROTAC or SNIPER design. The SLF core engages FKBP12, and the amido-C2-COOH modification provides a solvent-exposed attachment site for linkers to E3 ligase recruiters. In a bifunctional degrader, the SLF moiety binds FKBP12 while the recruiter promotes induced proximity with ubiquitination machinery. The intended function is ternary complex formation, target ubiquitination, and proteasome-mediated FKBP12 depletion. SLF-amido-C2-COOH is valuable for exploring FKBP12-targeted protein degradation, linker chemistry optimization, and comparative studies of ligand orientation on degradation efficiency.
Structure of 1092369-24-8
* For research and manufacturing use only. Not for human or clinical use.
| Size | Price | Stock | Quantity |
|---|---|---|---|
| -- | $-- | In stock |
Looking for different specifications? Click to request a custom quote!
Capabilities & Facilities
Popular Publications Citing BOC Sciences Products
Target: This ligand targets FK506-binding protein FKBP12 in biochemical or cellular target-engagement studies.
Mechanism of Action: Used as the target-protein recognition element, this ligand provides the binding interface for FK506-binding protein FKBP12. In PROTAC design, a derivatizable position on the ligand can be connected through an optimized linker to an E3 ligase ligand, such as a CRBN, VHL, or IAP recruiter, while preserving productive target engagement. The resulting bifunctional molecule brings FK506-binding protein FKBP12 into proximity with the recruited E3 ligase, enabling ternary-complex formation. If the complex has favorable geometry and residence time, target lysine ubiquitination is promoted, leading to proteasome-dependent degradation in experimental systems.
Applications• PROTAC E3 Ligase Recruitment: SLF-amido-C2-COOH can be used as a PROTAC ligand to recruit an E3 ubiquitin ligase, enabling proximity-driven ubiquitination of a chosen target protein. In targeted degradation studies, this scaffold supports systematic linker optimization to tune ternary complex formation, ubiquitin transfer efficiency, and resultant target knockdown potency.
• Targeted Protein Degradation Optimization: The ligand’s defined chemical functionality makes it suitable for building PROTACs aimed at improving degradation selectivity and potency. Researchers can vary attachment points and linker length to balance binding to both the target and the E3 ligase, thereby maximizing ubiquitin-dependent proteasomal turnover while minimizing off-target degradation.
• Ternary Complex Mechanism Studies: SLF-amido-C2-COOH–based PROTACs are well suited for dissecting the formation and stability of target–PROTAC–E3 ternary complexes. By comparing degradation profiles with biophysical or cell-based ubiquitination readouts, investigators can correlate ternary complex dynamics with degradation kinetics and determine whether degradation is driven by productive complex assembly.
• Proteasome-Dependent Pathway Validation: Incorporating SLF-amido-C2-COOH into PROTAC designs enables rigorous assessment of ubiquitin–proteasome dependence. Degradation can be evaluated under proteasome inhibition or ubiquitination pathway perturbation to confirm mechanism, quantify pathway engagement, and distinguish true degradation from reversible inhibition or transcriptional effects.
SLF-amido-C2-COOH is a FKBP-family ligand intended for use as the target-engaging component or reference ligand in PROTAC discovery workflows. Its known small-molecule recognition profile enables rational linker-vector evaluation and comparative degrader design. This molecule is described in detail below.
Structure: The structure of SLF-amido-C2-COOH is characterized by primary or secondary amine/basic nitrogen centers. These features provide defined hydrogen-bonding, hydrophobic, and steric elements that can support affinity retention while enabling analogue-based linker-vector selection.
Reactivity: The amine/basic nitrogen-containing motif can be evaluated for acylation, sulfonylation, alkylation, or carbamate/urea linker installation when that vector is solvent exposed. For FKBP-directed chemical biology, it may be connected to degradation or dimerization modules through flexible PEG/alkyl or amide-containing linkers, subject to FKBP-binding SAR. In practice, incorporation into PROTACs should begin from derivatives that preserve the reported binding pharmacophore, followed by systematic variation of linker length, polarity, rigidity, and exit-vector geometry to optimize target engagement, E3 recruitment, and cellular degradation readouts.
* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2
Please contact us with any specific requirements and we will get back to you as soon as possible.